Evrópusambandið -
íslenska -
EMA (European Medicines Agency)
neparvis
novartis europharm limited - sacubitril, valsartan - hjartabilun - lyf sem hafa áhrif á renín-angíótensín kerfið - paediatric heart failureneparvis is indicated in children and adolescents aged one year or older for treatment of symptomatic chronic heart failure with left ventricular systolic dysfunction (see section 5. adult heart failureneparvis is indicated in adult patients for treatment of symptomatic chronic heart failure with reduced ejection fraction (see section 5.
Ísland -
íslenska -
LYFJASTOFNUN (Icelandic Medicines Agency)
amiloride/hct alvogen (diuramin) tafla 5/50 mg
alvogen ehf. - amiloridum hýdróklóríð; hydrochlorothiazidum inn - tafla - 5/50 mg
Ísland -
íslenska -
LYFJASTOFNUN (Icelandic Medicines Agency)
enalapril-hydrochlorthiazid krka tafla 20 mg /12,5 mg
krka sverige ab - enalaprilum maleat; hydrochlorothiazidum inn - tafla - 20 mg /12,5 mg
Ísland -
íslenska -
LYFJASTOFNUN (Icelandic Medicines Agency)
enalapril krka tafla 5 mg
krka sverige ab - enalaprilum maleat - tafla - 5 mg
Ísland -
íslenska -
LYFJASTOFNUN (Icelandic Medicines Agency)
coversyl novum filmuhúðuð tafla 5 mg
les laboratoires servier* - perindoprilum arginín - filmuhúðuð tafla - 5 mg
Ísland -
íslenska -
LYFJASTOFNUN (Icelandic Medicines Agency)
daren tafla 10 mg
teva b.v.* - enalapril maleate - tafla - 10 mg
Ísland -
íslenska -
LYFJASTOFNUN (Icelandic Medicines Agency)
enalapril krka tafla 20 mg
krka sverige ab - enalaprilum maleat - tafla - 20 mg
Ísland -
íslenska -
LYFJASTOFNUN (Icelandic Medicines Agency)
kairasec tafla 8 mg
medical valley invest ab - candesartanum cílexetíl - tafla - 8 mg
Ísland -
íslenska -
LYFJASTOFNUN (Icelandic Medicines Agency)
daren tafla 20 mg
teva b.v.* - enalapril maleate - tafla - 20 mg
Ísland -
íslenska -
LYFJASTOFNUN (Icelandic Medicines Agency)
ramíl tafla 5 mg
teva b.v.* - ramiprilum inn - tafla - 5 mg